Your browser doesn't support javascript.
loading
Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan.
Kirino, Yohei; Takase-Minegishi, Kaoru; Tsuchida, Naomi; Hirahara, Lisa; Kunishita, Yosuke; Yoshimi, Ryusuke; Nakajima, Hideaki.
Afiliación
  • Kirino Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan kirino@yokohama-cu.ac.jp.
  • Takase-Minegishi K; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Tsuchida N; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Hirahara L; Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Kunishita Y; Department of Rare Disease Genomics, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.
  • Yoshimi R; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
  • Nakajima H; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Ann Rheum Dis ; 80(11): 1501-1502, 2021 11.
Article en En | MEDLINE | ID: mdl-34260381

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Policondritis Recurrente / Antirreumáticos / Anticuerpos Monoclonales Humanizados / Inflamación Límite: Aged / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Ann Rheum Dis Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Policondritis Recurrente / Antirreumáticos / Anticuerpos Monoclonales Humanizados / Inflamación Límite: Aged / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Ann Rheum Dis Año: 2021 Tipo del documento: Article País de afiliación: Japón